ENANTA PHARMACEUTICALS INC (ENTA) › Total LiabilitiesENANTA PHARMACEUTICALS INC (ENTA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2012: $8.23M2013: $6.50M2014: $6.76M2015: $9.86M2016: $11.34M2017: $24.96M2018: $20.55M2019: $27.34M2020: $30.55M2021: $39.36M2022: $54.08M2023: $245.54M2024: $247.84M2025: $216.01M$216.01M2012Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$216.01M-12.8%2024$247.84M+0.9%2023$245.54M+354.1%2022$54.08M+37.4%2021$39.36M+28.8%2020$30.55M+11.8%2019$27.34M+33.0%2018$20.55M-17.7%2017$24.96M+120.1%2016$11.34M+15.1%2015$9.86M+45.8%2014$6.76M+3.9%2013$6.50M-21.0%2012$8.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share